임상시험 트래커
추적 기업 30곳의 임상 6,982건 (국내 전체 이력 · 글로벌 진행 중). 출처: ClinicalTrials.gov
60건 표시 (상위 60건)
- 2상모집 중· Primary Brain TumorBelvarafenib for CNS Efficacy in Patients With BRAF-Altered Solid Tumors
협력: 한미약품
- 2상모집 중· Type 2 Diabetes MellitusStudy to Evaluate HM15275 in Subjects With Type 2 Diabetes Mellitus
리드: 한미약품
- 2상완료· Age-Related Macular DegenerationA Study to Evaluate the Usability of the SB11 PFS in Trial Participants With Wet AMD, Macular Oedema Secondary to RVO, or mCNV
리드: 삼성바이오에피스
- 2상모집 중· Advanced or Metastatic MelanomaBelvarafenib in Combination With Cobimetinib in Patients With Locally Advanced or Metastatic NRAS-Mutant Melanoma
리드: 한미약품
- 2상모집 중단 (진행 중)· ObeseStudy to Evaluate HM15275 in Obese or Overweight Subjects Without Diabetes Mellitus
리드: 한미약품
- 2상완료· Knee OsteoarthritisInitial Pilot Study to Evaluate the Safety and Temporary Symptom Improvement Efficacy of CKD-981
리드: 종근당
- 2상완료· Neovascular Age-related Macular DegenerationA Study to Evaluate the Usability of the SB11 PFS in Subjects With Wet AMD or Macular Oedema Secondary to RVO
리드: 삼성바이오에피스
- 2상상태 미확인· OsteoarthritisEfficacy of Probiotics for NSAID-induced Enteropathy in Arthritis Patients
협력: 대웅제약
- 2상완료· Androgenetic AlopeciaA Phase 2 Study to Evaluate the Safety and Efficacy of CKD-498 in Female Patients With Androgenetic Alopecia
리드: 종근당
- 2상모집 중단 (진행 중)· Idiopathic Pulmonary FibrosisClinical Trial to Evaluate the Safety and Efficacy of DWN12088 in Patients With IPF
리드: 대웅제약
- 2상상태 미확인· Non-small Cell Lung Cancer Stage IIIA Study of Lazertinib as Consolidation Therapy in Patients With Locally Advanced, Unresectable, EGFR-Mutant Non-Small Cell Lung Cancer (Stage III) Following Chemoradiation Therapy
협력: 유한양행
- 2상모집 중· Non Small Cell Lung CancerNeoadjuvant Lazertinib Therapy in EGFR-Mutation Positive Lung Adenocarcinoma Detected by BALF Liquid Biopsy
협력: 유한양행
- 2상모집 중단 (진행 중)· Congenital HyperinsulinismHM15136 (Efpegerglucagon) Treatment for 8 Weeks in Subjects Aged ≥2 Years With Congenital Hyperinsulinism (CHI)
리드: 한미약품
- 2상완료· Rash AcneiformDWP708 for Treating Epidermal Growth Factor Receptor Inhibitor Related Skin Toxicities
리드: 대웅제약
- 2상모집 중· Short Bowel SyndromePhase 2 Study to Assess the Safety, PK, and PD of Sonefpeglutide (HM15912) in SBS-IF Subjects
리드: 한미약품
- 2상조기 종료· Marginal Zone LymphomaPembrolizumab in MarginalzoneLymphoma A MULTICENTER OPEN LABEL SINGLE-ARM PHASE II STUDY
협력: 셀트리온
- 2상완료· Atopic DermatitisEfficacy and Safety of LEO 152020 Tablets for the Treatment of Adults With Moderate to Severe Atopic Dermatitis
리드: JW중외제약
- 2상완료· Gastric CancerFLX475 Combined With Pembrolizumab in Patients With Advanced or Metastatic Gastric Cancer
리드: 한미약품
- 2상완료· Cholinergic UrticariaTrial to Assess the Efficacy and Safety of LEO 152020 in Adult Patients With Cholinergic Urticaria
리드: JW중외제약
- 2상완료· HypertensionA Phase 2 Study to Explore the Dose of HCP1803 in Patients With Essential Hypertension
리드: 한미약품
- 2상완료· Rotavirus VaccineMixed Schedule Study of Live Oral Rotavirus Vaccines and Trivalent P2-VP8 Subunit Rotavirus Vaccine
협력: SK바이오사이언스
- 2상상태 미확인· Urachal CancerA Multicenter Prospective Phase II Study of Modified FOLFIRINOX for 1st Line Treatment for Advanced Urachus Cancer
협력: GC녹십자
- 2상모집 중· Primary CNS LymphomaStudy of Lenalidomide/Rituximab Maintenance for Transplantation Ineligible Patients With PCNSL.
협력: 셀트리온
- 2상모집 중단 (진행 중)· NASH - Nonalcoholic SteatohepatitisStudy to Evaluate Efficacy, Safety and Tolerability of HM15211(Efocipegtrutide) in Subjects
리드: 한미약품
- 2상상태 미확인· Primary Open Angle GlaucomaA Clinical Study to Evaluate the Efficacy and Safety of CKD-351
리드: 종근당
- 2상모집 중단 (진행 중)· Marginal Zone LymphomaCopanlisib and Rituximab in Marginal Zone Lymphoma Patients
협력: 셀트리온
- 2상완료· Autoimmune EncephalitisSafety and Efficacy of IGIV 10% in Patients With Autoimmune Encephalitis:
리드: GC녹십자
- 2상상태 미확인· TetanusA Study to Evaluate the Safety and Efficacy(Immunogenicity) of GC3111 in Healthy Adults
리드: GC녹십자
- 2상상태 미확인· T2DM (Type 2 Diabetes Mellitus)Study to Evaluate the Efficacy and Safety of DWP16001 in Patients With Type 2 Diabetes Mellitus
리드: 대웅제약
- 2상상태 미확인· Hepatitis BA Study of GC1102(Recombinant Hepatitis B Immunoglobulin) in Chronic Hepatitis B Patients
리드: GC녹십자
- 2상상태 미확인· Primary CNS Lymphoma[CREMA]Combination of R-M Followed by R-A in Elderly Patients With Primary CNS Lymphoma
협력: 셀트리온
- 2상완료· Influenza, HumanA Study to Evaluate the Safety and Efficacy(Immunogenicity) of GC3114 in Elderly Healthy Subjects
리드: GC녹십자
- 2상상태 미확인· Leiomyosarcoma MetastaticAvelumab in Combination With Gemcitabine in Advanced Leiomyosarcoma as a Second-line Treatment
협력: 종근당
- 2상완료· TyphoidSafety, Reactogenicity and Immunogenicity of Vi-DT;Typhoid Conjugate Vaccine
협력: SK바이오사이언스
- 2상상태 미확인· Urothelial CarcinomaThe Effectiveness and Safety of Intravesical Gemcitabine Instillation to Prevent Intravesical Recurrence
협력: 종근당
- 2상상태 미확인· EGFR Positive Non-small Cell Lung CancerRetreatment With Epidermal Growth Factor Receptor(EGFR) Tyrosine Kinase Inhibitor in EGFR Mutation Positive Patients
협력: 종근당
- 2상상태 미확인· Benign Masseteric HypertrophyDWP450 Treatment in Subjects With Benign Masseteric Hypertrophy
리드: 대웅제약
- 2상완료· Treatment for Submental FatClinicial Trial to Evaluate the Efficacy and Safety of DWJ211 in Patient With Moderate or Severe Submental Fat
리드: 대웅제약
- 2상완료· Erosive Gastroesophageal Reflux DiseaseStudy to Evaluate the Efficacy and Safety of DWP14012 in Patients With Erosive Gastroesophageal Reflux Disease (Phase 2, Therapeutic Exploratory Study)
리드: 대웅제약
- 2상완료· Non Small Cell Lung CancerOlmutinib Trial in T790M (+) NSCLC Patients Detected by Liquid Biopsy Using BALF Extracellular Vesicular DNA
협력: 한미약품
- 2상상태 미확인· Glaucoma, Primary Open AngleExploratory Trial to Evaluate the Efficacy and Safety of D565H Twice Daily Versus D565 Once Daily
리드: 종근당
BioPulse가 제공하는 정보는 공개된 자료를 요약·정리한 것으로, 투자 조언이나 의료 조언이 아닙니다. 임상 데이터·규제 일정·공시 내용은 반드시 원문을 직접 확인하시기 바랍니다.